UPDATE: Syros Pharmaceuticals (SYRS) PT Raised to $23 at Roth Capital Sep 23, 2021 08:27AM
Syros Pharmaceuticals (SYRS) Prices 5.4M Share Common Offering at $14/Sh Jan 20, 2021 06:22AM
Syros Announces Pricing of $75.6 Million Public Offering of Common Stock Jan 19, 2021 10:41PM
Syros Pharmaceuticals (SYRS) PT Raised to $20 at Roth Capital After Phase 1 Data Announcement Oct 27, 2020 06:40AM
Roth Capital Assumes Syros Pharmaceuticals (SYRS) at Buy Jul 12, 2019 02:16PM


Apr 23, 2019 12:06PM NetworkNewsBreaks – Syros Pharmaceuticals (NASDAQ: SYRS) Realizes Proceeds of Approximately $70M Through Concurrent Public Offerings
Apr 9, 2019 04:01PM Syros Announces Closing of Concurrent Public Offerings
Apr 5, 2019 07:16AM Syros Pharmaceuticals (SYRS) Announces Pricing of $70 Million Concurrent Public Offerings
Apr 4, 2019 04:19PM Syros Pharmaceuticals (SYRS) Proposed Concurrent Offerings of Common Stock with Warrants and Preferred Stock with Warrants
Nov 5, 2018 07:31AM Roth Capital Upgrades Syros Pharmaceuticals (SYRS) to Buy
Aug 13, 2018 10:39AM Syros Pharmaceuticals (SYRS) PT Lowered to $12 at Roth Capital
Oct 23, 2017 07:33AM Roth Capital Starts Syros Pharmaceuticals (SYRS) at Neutral